Summaries by Inventor Yoo, Andrew
Oh, Youngmi ; Yoo, Andrew
T-020121
— Technology Description Researchers in Andrew Yoo’s laboratory at Washington University have developed an antisense oligonucleotide targeting a miRNA (miR-29b-3p) as a treatment for Huntington’s disease (HD). Inhibiting miR-29b-3p promotes neuronal survival by rescuing neurons from deg…
Antisense oligo to enhance neuronal survival in Huntington’s DiseaseOh, Youngmi ; Yoo, Andrew
T-020121
— Technology Description Researchers in Andrew Yoo’s laboratory at Washington University have developed an antisense oligonucleotide targeting a miRNA (miR-29b-3p) as a treatment for Huntington’s disease (HD). Inhibiting miR-29b-3p promotes neuronal survival by rescuing neurons from deg…
MicroRNA-induced Direct Conversion of Human Adult Fibroblasts into NeuronsAbernathy, Daniel ; Yoo, Andrew
T-017136
— Background: Studying late-onset neurodegenerative disorders using patient-specific neurons is one of the primary goals of precision medicine. The ability to generate human neurons that mimic the neurons of elderly individuals will provide an instrumental platform to model and study adult-onset neuro…
